Catalyst Wire Dossier Catalyst Wire Dossier

Tekturna

aliskiren · Takeda Pharmaceutical Company
Drug timelines are a Plus or Pro feature.

57 regulatory and trial events tracked for Tekturna, covering 2007-06-22 to 2024-12-05. Get the full timeline:

Most recent: Clinical Trial Update: Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia [Phase 4]

See pricing